These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25153593)

  • 21. Structural Basis for the Selective Inhibition of c-Jun N-Terminal Kinase 1 Determined by Rigid DARPin-DARPin Fusions.
    Wu Y; Honegger A; Batyuk A; Mittl PRE; Plückthun A
    J Mol Biol; 2018 Jul; 430(14):2128-2138. PubMed ID: 29126898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of caspase-2 by a designed ankyrin repeat protein: specificity, structure, and inhibition mechanism.
    Schweizer A; Roschitzki-Voser H; Amstutz P; Briand C; Gulotti-Georgieva M; Prenosil E; Binz HK; Capitani G; Baici A; Plückthun A; Grütter MG
    Structure; 2007 May; 15(5):625-36. PubMed ID: 17502107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facile double-functionalization of designed ankyrin repeat proteins using click and thiol chemistries.
    Simon M; Zangemeister-Wittke U; Plückthun A
    Bioconjug Chem; 2012 Feb; 23(2):279-86. PubMed ID: 22188139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Designed ankyrin repeat proteins (DARPins) from research to therapy.
    Tamaskovic R; Simon M; Stefan N; Schwill M; Plückthun A
    Methods Enzymol; 2012; 503():101-34. PubMed ID: 22230567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knowledge-based design of reagentless fluorescent biosensors from a designed ankyrin repeat protein.
    Brient-Litzler E; Plückthun A; Bedouelle H
    Protein Eng Des Sel; 2010 Apr; 23(4):229-41. PubMed ID: 19945965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-crystallization with conformation-specific designed ankyrin repeat proteins explains the conformational flexibility of BCL-W.
    Schilling J; Schöppe J; Sauer E; Plückthun A
    J Mol Biol; 2014 Jun; 426(12):2346-62. PubMed ID: 24747052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of a consensus-designed ankyrin repeat protein: implications for stability.
    Binz HK; Kohl A; Plückthun A; Grütter MG
    Proteins; 2006 Nov; 65(2):280-4. PubMed ID: 16493627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DARPins: a true alternative to antibodies.
    Stumpp MT; Amstutz P
    Curr Opin Drug Discov Devel; 2007 Mar; 10(2):153-9. PubMed ID: 17436550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size.
    Zahnd C; Kawe M; Stumpp MT; de Pasquale C; Tamaskovic R; Nagy-Davidescu G; Dreier B; Schibli R; Binz HK; Waibel R; Plückthun A
    Cancer Res; 2010 Feb; 70(4):1595-605. PubMed ID: 20124480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solution structure of the human oncogenic protein gankyrin containing seven ankyrin repeats and analysis of its structure--function relationship.
    Yuan C; Li J; Mahajan A; Poi MJ; Byeon IJ; Tsai MD
    Biochemistry; 2004 Sep; 43(38):12152-61. PubMed ID: 15379554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular dynamics study of the stabilities of consensus designed ankyrin repeat proteins.
    Yu H; Kohl A; Binz HK; Plückthun A; Grütter MG; van Gunsteren WF
    Proteins; 2006 Nov; 65(2):285-95. PubMed ID: 16948156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designed ankyrin repeat proteins as anti-idiotypic-binding molecules.
    Vogel M; Keller-Gautschi E; Baumann MJ; Amstutz P; Ruf C; Kricek F; Stadler BM
    Ann N Y Acad Sci; 2007 Aug; 1109():9-18. PubMed ID: 17785285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural and kinetic analysis of caspase-3 reveals role for s5 binding site in substrate recognition.
    Fang B; Boross PI; Tozser J; Weber IT
    J Mol Biol; 2006 Jul; 360(3):654-66. PubMed ID: 16781734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries.
    Amstutz P; Koch H; Binz HK; Deuber SA; Plückthun A
    Protein Eng Des Sel; 2006 May; 19(5):219-29. PubMed ID: 16551653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid selection of high-affinity binders using ribosome display.
    Dreier B; Plückthun A
    Methods Mol Biol; 2012; 805():261-86. PubMed ID: 22094811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective detection of caspase-3 versus caspase-7 using activity-based probes with key unnatural amino acids.
    Vickers CJ; González-Páez GE; Wolan DW
    ACS Chem Biol; 2013 Jul; 8(7):1558-66. PubMed ID: 23614665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation.
    Keller N; Mares J; Zerbe O; Grütter MG
    Structure; 2009 Mar; 17(3):438-48. PubMed ID: 19278658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex.
    Blanchard H; Donepudi M; Tschopp M; Kodandapani L; Wu JC; Grütter MG
    J Mol Biol; 2000 Sep; 302(1):9-16. PubMed ID: 10964557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex.
    Xu G; Cirilli M; Huang Y; Rich RL; Myszka DG; Wu H
    Nature; 2001 Mar; 410(6827):494-7. PubMed ID: 11260720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis for eliciting a cytotoxic effect in HER2-overexpressing cancer cells via binding to the extracellular domain of HER2.
    Jost C; Schilling J; Tamaskovic R; Schwill M; Honegger A; Plückthun A
    Structure; 2013 Nov; 21(11):1979-91. PubMed ID: 24095059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.